Inhibrx Biosciences, Inc.
INBX
$14.00
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -47.87M | -43.86M | 1.83B | -49.27M | -93.60M |
| Total Depreciation and Amortization | 689.00K | 760.00K | 476.00K | 360.00K | 298.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 2.07M | -- | 1.25M |
| Total Other Non-Cash Items | 3.45M | 3.46M | -1.95B | 5.51M | 6.88M |
| Change in Net Operating Assets | 4.00K | 9.36M | 39.60M | 3.09M | 28.36M |
| Cash from Operations | -43.72M | -30.28M | -80.09M | -40.31M | -56.82M |
| Capital Expenditure | -16.00K | -247.00K | -1.22M | -1.12M | -3.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -247.00K | -1.22M | -1.12M | -3.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 71.68M | -- | 1.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -41.43M | 41.43M | -225.00K |
| Cash from Financing | 0.00 | 0.00 | 30.25M | 41.43M | 860.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.74M | -30.53M | -51.06M | -- | -59.40M |
